Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,587 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011.
Cleveland AA, Farley MM, Harrison LH, Stein B, Hollick R, Lockhart SR, Magill SS, Derado G, Park BJ, Chiller TM. Cleveland AA, et al. Among authors: stein b. Clin Infect Dis. 2012 Nov 15;55(10):1352-61. doi: 10.1093/cid/cis697. Epub 2012 Aug 14. Clin Infect Dis. 2012. PMID: 22893576 Free PMC article.
Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.
Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, Chiller T. Lockhart SR, et al. Among authors: stein b. J Clin Microbiol. 2012 Nov;50(11):3435-42. doi: 10.1128/JCM.01283-12. Epub 2012 Aug 8. J Clin Microbiol. 2012. PMID: 22875889 Free PMC article.
The interplay of personality pathology and treatment outcome in psychosomatic psychotherapy: A longitudinal analysis using latent change score modelling.
Bierling AL, Doering S, Weidner K, Pape M, Kessler H, Hofmann T, Rose M, Imbierowicz K, Geiser F, Rademacher J, Michalek S, Morawa E, Erim Y, Schneider JS, Teufel M, Hartmann A, Lahmann C, Peters EMJ, Kruse J, von Boetticher D, Herrmann-Lingen C, Nöhre M, de Zwaan M, Dinger U, Friederich HC, Niecke A, Albus C, Zwerenz R, Beutel M, Sattel HC, Henningsen P, Stein B, Waller C, Hake K, Spitzer C, Stengel A, Zipfel S, Weimer K, Gündel H, Herpertz S, Croy I. Bierling AL, et al. Among authors: stein b. Compr Psychiatry. 2024 Nov;135:152532. doi: 10.1016/j.comppsych.2024.152532. Epub 2024 Sep 23. Compr Psychiatry. 2024. PMID: 39341174 Free article.
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6.
Hughes BGM, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, Grob JJ, Lewis KD, Ansstas G, Day F, Ladwa R, Stein BN, Muñoz Couselo E, Meier F, Hauschild A, Schadendorf D, Basset-Seguin N, Modi B, Dalac-Rat S, Dunn LA, Flatz L, Mortier L, Guégan S, Heinzerling LM, Mehnert JM, Trabelsi S, Soria-Rivas A, Stratigos AJ, Ulrich C, Wong DJ, Beylot-Barry M, Bossi P, Bugés Sánchez C, Chandra S, Robert C, Russell JS, Silk AW, Booth J, Yoo SY, Seebach F, Lowy I, Fury MG, Rischin D. Hughes BGM, et al. Among authors: stein bn. J Am Acad Dermatol. 2024 Sep 7:S0190-9622(24)02770-1. doi: 10.1016/j.jaad.2024.06.108. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39245360
1,587 results